Back to Search Start Over

DECIDE: <u>D</u>elphi <u>E</u>xpert <u>C</u>onsensus Statement on <u>I</u>nflammatory Bowel Disease <u>D</u>ysplasia Shar<u>e</u>d Management Decision-Making

Authors :
Misha Kabir
Siwan Thomas-Gibson
Phil J Tozer
Janindra Warusavitarne
Omar Faiz
Ailsa Hart
Lisa Allison
Austin G Acheson
Semra Demirli Atici
Pearl Avery
Mantaj Brar
Michele Carvello
Matthew C Choy
Robin J Dart
Justin Davies
Anjan Dhar
Shahida Din
Bu'Hussain Hayee
Kesavan Kandiah
Konstantinos H Katsanos
Christopher Andrew Lamb
Jimmy K Limdi
Richard E Lovegrove
Pär Myrelid
Nurulamin Noor
Ioannis Papaconstantinou
Dafina Petrova
Polychronis Pavlidis
Thomas Pinkney
David Proud
Shellie Radford
Rohit Rao
Shaji Sebastian
Jonathan P Segal
Christian Selinger
Antonino Spinelli
Kathryn Thomas
Albert Wolthuis
Ana Wilson
Source :
Kabir, M, Thomas-Gibson, S, Tozer, P J, Warusavitarne, J, Faiz, O, Hart, A, Allison, L, Acheson, A G, Atici, S D, Avery, P, Brar, M, Carvello, M, Choy, M C, Dart, R J, Davies, J, Dhar, A, Din, S, Hayee, B, Kandiah, K, Katsanos, K H, Lamb, C A, Limdi, J K, Lovegrove, R E, Myrelid, P, Noor, N, Papaconstantinou, I, Petrova, D, Pavlidis, P, Pinkney, T, Proud, D, Radford, S, Rao, R, Sebastian, S, Segal, J P, Selinger, C, Spinelli, A, Thomas, K, Wolthuis, A & Wilson, A 2023, ' DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making ', Journal of Crohn's and Colitis . https://doi.org/10.1093/ecco-jcc/jjad083
Publication Year :
2023
Publisher :
Oxford University Press (OUP), 2023.

Abstract

Background and Aims Inflammatory Bowel Disease colitis-associated dysplasia is managed with either enhanced surveillance and endoscopic resection or prophylactic surgery. The rate of progression to cancer after a dysplasia diagnosis remains uncertain in many cases and patients have high thresholds for accepting proctocolectomy. Individualised discussion of management options is encouraged to take place between patients and their multidisciplinary teams for best outcomes. We aimed to develop a toolkit to support a structured, multidisciplinary and shared decision-making approach to discussions about dysplasia management options between clinicians and their patients. Methods Evidence from systematic literature reviews, mixed-methods studies conducted with key stakeholders and decision-making expert recommendations were consolidated to draft consensus statements by the DECIDE steering group. These were then subjected to an international, multidisciplinary modified electronic Delphi process until an a priori threshold of 80% agreement was achieved to establish consensus for each statement. Results 31 members (15 gastroenterologists, 14 colorectal surgeons and two nurse specialists) from 9 countries formed the Delphi panel. We present the 18 consensus statements generated after two iterative rounds of anonymous voting. Conclusions By consolidating evidence for best practice using literature review, key stakeholder and decision-making expert consultation we have developed international consensus recommendations to support healthcare professionals counselling patients on the management of high cancer risk colitis-associated dysplasia. The final toolkit includes clinician and patient decision aids to facilitate shared decision-making.

Details

ISSN :
18764479 and 18739946
Database :
OpenAIRE
Journal :
Journal of Crohn's and Colitis
Accession number :
edsair.doi.dedup.....af073a70a256d0a9c4f870bc11e99a65
Full Text :
https://doi.org/10.1093/ecco-jcc/jjad083